as on October 28, 2025 at 1:29 am IST
Day's High
0.04%
Upside
52 Week's Low
52 Week's High
75.91%
Downside
0.60%
Upside
Check Tourmaline Bio market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.2B
EPS (TTM)
-3.804
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-102.4M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-29.62%
Compare market cap, revenue, PE, and other key metrics of Tourmaline Bio with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $1.2B | NA | NA | 0.00% | |
| BUY | $62.7B | 285.91% | -505.15 | -12.96% | |
| NA | $36.5B | NA | NA | -3.89% | |
| BUY | $108.0B | 104.04% | 29.95 | 31.86% | |
| BUY | $62.0B | 17.76% | 14.75 | 31.37% |
Based on 12 analysts
91.67%
Buy
8.33%
Hold
0.00%
Sell
Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Tourmaline Bio. Average target price of $48
Get share price movements and forecasts by analysts on Tourmaline Bio.
What analysts predicted
0.04%UPSIDE
Target Price
$48
Current Price
$47.98
Analyzed by
12 Analysts
Target
$48.00
Tourmaline Bio target price $48, a slight upside of 0.04% compared to current price of $47.98. According to 12 analysts rating.
Search interest for Tourmaline Bio Stock has decreased by -59% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 09 September
Tue, 09:24 PM
-Novartis offers $48 per share for Tourmaline Bio, a 60% premium, boosting TRML shares significantly.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 3 Years
![]()
In the last 3 years, TRML has outperformed top 5 stocks with highest market-cap in its industry
Price Rise
![]()
In the last 3 years, TRML stock has moved up by 2917.6%
Best in 1 Year
![]()
In the last 1 year, TRML has outperformed top 5 stocks with highest market-cap in its industry
| Organisation | Tourmaline Bio |
| Headquarters | 27 West 24th Street, New York, NY, United States, 10010 |
| CEO | Dr. Sandeep C. Kulkarni M.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Sandeep C. Kulkarni M.D. | Co-Founder, CEO & Director |
Ms. Kimberly Piorkowski | Vice President of People, Culture & Compliance |
Ms. Dora Rau | Senior VP & Head of Quality |
Mr. Gerhard Hagn Pharm.D. | Chief Commercial Officer |
Mr. Ryan Robinson CPA | CFO & Treasurer |
Mr. W. Bradford Middlekauff J.D. | Chief Business Officer, General Counsel & Corporate Secretary |
Dr. Susan Dana Jones Ph.D. | Chief Technology Officer |
Dr. Kevin B. Johnson M.B.A., Ph.D. | Chief Regulatory Officer |
Dr. Emil M. deGoma M.D. | Senior Vice President of Medical Research |
Dr. Kristine Erickson O.D., Ph.D. | VP & TA Head of Ophthalmology, Medical Research |
Tourmaline Bio share price today is $47.98 as on at the close of the market. Tourmaline Bio share today touched a day high of $48 and a low of $47.98.
Tourmaline Bio share touched a 52 week high of $48.27 on and a 52 week low of $11.56 on . Tourmaline Bio stock price today i.e. is closed at $47.98,which is 0.60% down from its 52 week high and 315.05% up from its 52 week low.
Tourmaline Bio market capitalisation is $0.00T as on .
Indian investors can start investing in Tourmaline Bio (TRML) shares with as little as ₹88.178 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.78 in Tourmaline Bio stock (as per the Rupee-Dollar exchange rate as on ).
Based on Tourmaline Bio share’s latest price of $47.98 as on October 28, 2025 at 1:29 am IST, you will get 0.2084 shares of Tourmaline Bio. Learn more about
fractional shares .